powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1396162368
Eliud Sifonte Rodriguez
MD
Endocrinology
New York,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
PRESCRIBING · PART D · 2024
Total Rx claims
3,481
Beneficiaries
—
Total drug cost
$1.8M
Distinct drugs
43
Brand share
46.0%
Top prescribed drugs
Levothyroxine Sodium
468 claims
Semaglutide
299 claims
Tirzepatide
256 claims
Atorvastatin Calcium
186 claims
Rosuvastatin Calcium
182 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,028
Unique beneficiaries
—
Total services
24,160
Distinct HCPCS
10
Medicare payment
$342K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 627 Endocrinology providers in NY — top quintile (cohort median 837).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$803
Payment records
40
By payment type
Food and Beverage
$803
Top paying entities
Food and Beverage
$803
QUALITY · MIPS · 2024
Final MIPS score
90.8
Quality
91.8
Cost
75.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.66%
Group